Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: Patient Voice in the Treatment of Low-grade Gliomas: Use of Patient-reported Outcomes, Vorasidenib and Radiotherapy Compared

View source ↗

Summary

A clinical trial update describing a study in low-grade gliomas evaluating patient-reported outcomes with vorasidenib in combination with radiotherapy, currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vorasidenib (vorasidenib)

Snippet

Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | Conditions: Glioma, Glioma of Brain | Status: RECRUITING